Patient Access
The G7 continuous glucose monitoring system will have a 15.5-day wear time and last 15% longer than Dexcom G7, according to the company.
HIMSS25
Luis Belén, CEO of NHIT, discusses how his personal history in Puerto Rico and the Bronx, as well as his cancer journey, have shaped his work in increasing care access for underserved communities.
The company will use the funds to grow its provider base and expand to Ohio.
In January, Transcarent announced it was acquiring Accolade and taking it private.
It has added sign language-based telehealth and chatbot features.
The research initiative aims to enhance the Galaxy Watch’s sleep apnea detection feature and ultimately create AI-powered tools for proactive sleep health management.
The alliance allows Flatiron Health to use Massive Bio's database to match oncology patients to clinical trials within their proximity.
The acquisition brings the parties' cross-litigation alleging patent infringements to a close.
HIMSS25
Sumit Nagpal, Cherish Health CEO, explains how the company prioritizes the look of its products and the emotions they evoke to give patients more confidence about deploying them in their homes.
Lark's cardiometabolic care coaching programs will be made accessible through CVS Caremark's Point Solutions Management program.